Cervical Cancer
Combining the SLP Vaccine With Chemo-immunotherapy in Order to Increase the HPV-specific T-cell Response in Cervical Cancer
Latest in Oncology
Cancer Treatment
Leukemia Drug Linked to Development of Blood Clots
Oct 21, 2013
| Business of Medicine, Cardiology, Critical Care, Human Interest, Internal Medicine, Oncology, Public Health & Prevention, Pulmonary Medicine, The Daily Dose
Reuters reports that Adriad Pharmaceuticals Inc. has discontinued a late-stage trial of its leukemia drug, Iclusig. The drug, which was approved by the FDA for two forms of blood cancer, has now been shown to cause blood clots. Though the drug's shares have now plunged to a three-year low of $2.62, it still...
Reuters Health • The Doctor's Channel Daily Newscast
Endosonography More Cost-Effective Than Surgical Staging in Lung Cancer
Oct 21, 2013
| Oncology, Pulmonary Medicine, Radiology, Reuters Health • The Doctor's Channel Newscast, Surgery
NEW YORK (Reuters Health) – A European study indicates that starting with endosonography for assessing mediastinal lymph node status in potentially resectable lung cancer is more cost-effective than immediate surgical staging – at least in the UK, The Netherlands and Belgium where the study was...
Reuters Health • The Doctor's Channel Daily Newscast
Pomalidomide-Dexamethasone Beneficial in Refractory Multiple Myeloma
NEW YORK (Reuters Health) – The combination of pomalidomide and low-dose dexamethasone improves survival in patients with advanced multiple myeloma more than does treatment with high-dose dexamethasone alone, a multinational study has shown.
“Pomalidomide plus low-dose dexamethasone, an oral regimen,...
WHO Classifies Air Pollution as Group 1 Carcinogen
Oct 17, 2013
Scientists “On the Hunt” for Breast Cancer Vaccine
Oct 16, 2013
